The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real‐world multicenter study

Bibliographic Details
Main Authors: Xiaochen Fei, Liancheng Fan, Wei Chen, Yiming Gong, Xinxing Du, Yanqing Wang, Yinjie Zhu, Jiahua Pan, Fangqin Wang, Wanbing Zhao, Tongtong Liu, Yining Yang, Baijun Dong, Wei Xue
Format: Article
Language:English
Published: Wiley 2021-10-01
Series:Clinical and Translational Medicine
Online Access:https://doi.org/10.1002/ctm2.527
_version_ 1797985717479014400
author Xiaochen Fei
Liancheng Fan
Wei Chen
Wei Chen
Yiming Gong
Xinxing Du
Yanqing Wang
Yinjie Zhu
Jiahua Pan
Fangqin Wang
Wanbing Zhao
Tongtong Liu
Yining Yang
Baijun Dong
Wei Xue
author_facet Xiaochen Fei
Liancheng Fan
Wei Chen
Wei Chen
Yiming Gong
Xinxing Du
Yanqing Wang
Yinjie Zhu
Jiahua Pan
Fangqin Wang
Wanbing Zhao
Tongtong Liu
Yining Yang
Baijun Dong
Wei Xue
author_sort Xiaochen Fei
collection DOAJ
first_indexed 2024-04-11T07:22:28Z
format Article
id doaj.art-c977e246e0d84390869ce0a39c3c7db2
institution Directory Open Access Journal
issn 2001-1326
language English
last_indexed 2024-04-11T07:22:28Z
publishDate 2021-10-01
publisher Wiley
record_format Article
series Clinical and Translational Medicine
spelling doaj.art-c977e246e0d84390869ce0a39c3c7db22022-12-22T04:37:10ZengWileyClinical and Translational Medicine2001-13262021-10-011110n/an/a10.1002/ctm2.527The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real‐world multicenter studyXiaochen Fei0Liancheng Fan1Wei Chen2Wei Chen3Yiming Gong4Xinxing Du5Yanqing Wang6Yinjie Zhu7Jiahua Pan8Fangqin Wang9Wanbing Zhao10Tongtong Liu11Yining Yang12Baijun Dong13Wei Xue14Department of Urology Renji Hospital School of Medicine Shanghai Jiao Tong University Shanghai ChinaDepartment of Urology Renji Hospital School of Medicine Shanghai Jiao Tong University Shanghai ChinaDepartment of Urology The First Affiliated Hospital of Wenzhou Medical University Zhejiang ChinaDepartment of Urology Zhongshan Hospital Shanghai Medical College Fudan University Shanghai ChinaDepartment of Urology Renji Hospital School of Medicine Shanghai Jiao Tong University Shanghai ChinaDepartment of Urology Renji Hospital School of Medicine Shanghai Jiao Tong University Shanghai ChinaDepartment of Urology Renji Hospital School of Medicine Shanghai Jiao Tong University Shanghai ChinaDepartment of Urology Renji Hospital School of Medicine Shanghai Jiao Tong University Shanghai ChinaDepartment of Urology Renji Hospital School of Medicine Shanghai Jiao Tong University Shanghai ChinaGloriousMedTechnologyCo. Ltd Shanghai ChinaGloriousMedTechnologyCo. Ltd Shanghai ChinaGloriousMedTechnologyCo. Ltd Shanghai ChinaGloriousMedTechnologyCo. Ltd Shanghai ChinaDepartment of Urology Renji Hospital School of Medicine Shanghai Jiao Tong University Shanghai ChinaDepartment of Urology Renji Hospital School of Medicine Shanghai Jiao Tong University Shanghai Chinahttps://doi.org/10.1002/ctm2.527
spellingShingle Xiaochen Fei
Liancheng Fan
Wei Chen
Wei Chen
Yiming Gong
Xinxing Du
Yanqing Wang
Yinjie Zhu
Jiahua Pan
Fangqin Wang
Wanbing Zhao
Tongtong Liu
Yining Yang
Baijun Dong
Wei Xue
The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real‐world multicenter study
Clinical and Translational Medicine
title The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real‐world multicenter study
title_full The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real‐world multicenter study
title_fullStr The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real‐world multicenter study
title_full_unstemmed The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real‐world multicenter study
title_short The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real‐world multicenter study
title_sort prevalence and clinical implication of rare germline deleterious alterations in chinese patients with prostate cancer a real world multicenter study
url https://doi.org/10.1002/ctm2.527
work_keys_str_mv AT xiaochenfei theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy
AT lianchengfan theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy
AT weichen theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy
AT weichen theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy
AT yiminggong theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy
AT xinxingdu theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy
AT yanqingwang theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy
AT yinjiezhu theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy
AT jiahuapan theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy
AT fangqinwang theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy
AT wanbingzhao theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy
AT tongtongliu theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy
AT yiningyang theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy
AT baijundong theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy
AT weixue theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy
AT xiaochenfei prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy
AT lianchengfan prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy
AT weichen prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy
AT weichen prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy
AT yiminggong prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy
AT xinxingdu prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy
AT yanqingwang prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy
AT yinjiezhu prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy
AT jiahuapan prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy
AT fangqinwang prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy
AT wanbingzhao prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy
AT tongtongliu prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy
AT yiningyang prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy
AT baijundong prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy
AT weixue prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy